Clinical Trials Browser

Neoplasms, Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT06510010 2026-01-26

Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer

Phase 2 Recruiting

198 enrolled

Chemotherapy Effect

NCT04930991 2026-01-08

OU202005AJ

Phase EARLY_PHASE1 Recruiting

60 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT02950259 2025-12-03

Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)

Phase 1 Completed

16 enrolled 10 charts

Breast

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT05680870 2025-09-09

The Possible Protective Role of Omeprazole Against Oxaliplatin Induced Neuropathy in Cancer Patients

Phase 3 Completed

46 enrolled

Gastrointestinal

Pancreatic Neoplasms, Peripheral Nervous System Diseases, Colorectal Neoplasms

NCT06383338 2025-09-08

PEGASUS

Phase 1 Recruiting

10 enrolled

Lymphoid

Hodgkin Disease, Lymphoma, Non-Hodgkin

NCT06150898 2025-06-13

KePreSt

Phase 2 Recruiting

112 enrolled

BreastOther

Breast Neoplasms, Inflammation, Obesity

NCT07016737 2025-06-12

ESO-Nanjing12

Phase 3 Enrolling by invitation

79 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT03267680 2025-04-13

IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3

Phase 2 Terminated

10 enrolled 19 charts

Gynecologic

Uterine Cervical Dysplasia

Clinical Trials

FASN

Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer

OU202005AJ

Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)

The Possible Protective Role of Omeprazole Against Oxaliplatin Induced Neuropathy in Cancer Patients

PEGASUS

KePreSt

ESO-Nanjing12

IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3